Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis.
Diabetes Metab Syndr
; 15(6): 102308, 2021.
Article
in English
| MEDLINE | ID: covidwho-1517128
ABSTRACT
BACKGROUND AND AIMS:
This meta-analysis aims to highlight the impact of cardio-metabolic comorbidities on COVID-19 severity and mortality.METHODS:
A thorough search on major online databases was done for studies describing the clinical outcomes of COVID-19 patients. We used random-effects model to compute pooled estimates for critical or fatal disease.RESULTS:
A total of 20,475 patients from 33 eligible studies were included. Maximum risk of development of critical or fatal COVID-19 disease was seen in patients with underlying cardiovascular disease [OR 3.44, 95% CI 2.65-4.48] followed by chronic lung disease, hypertension and diabetes mellitus. Of the total cases, 64% had one of the four comorbidities with the most prevalent being hypertension with a pooled prevalence of 27%.CONCLUSIONS:
Presence of comorbidities like cardiovascular disease, chronic lung disease, hypertension and diabetes mellitus led to a higher risk of development of critical or fatal COVID-19 disease, with maximum risk seen with underlying cardiovascular disease.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
/
Diabetes Mellitus
/
SARS-CoV-2
/
COVID-19
/
Hypertension
/
Lung Diseases
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
/
Reviews
/
Systematic review/Meta Analysis
Limits:
Humans
Language:
English
Journal:
Diabetes Metab Syndr
Year:
2021
Document Type:
Article
Affiliation country:
J.dsx.2021.102308
Similar
MEDLINE
...
LILACS
LIS